Litigation Details for Harmony Biosciences, LLC v. AET Pharma US, Inc. (D. Del. 2023)
✉ Email this page to a colleague
Harmony Biosciences, LLC v. AET Pharma US, Inc. (D. Del. 2023)
| Docket | ⤷ Sign Up | Date Filed | 2023-11-21 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Jennifer L. Hall |
| Jury Demand | None | Referred To | |
| Parties | BIOPROJET SOCIETE CIVILE DE RECHERCHE | ||
| Patents | 8,207,197; 8,354,430; 8,486,947 | ||
| Attorneys | Jeremy A. Tigan | ||
| Firms | Heyman Enerio Gattuso & Hirzel LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Harmony Biosciences, LLC v. AET Pharma US, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Harmony Biosciences, LLC v. AET Pharma US, Inc. (D. Del. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2023-11-21 | 3 | ANDA Form | Expiration of Patent: U.S. Patent No. 8,486,947 expires on September 26, 2029; U.S. Patent No. 8,207,197 expires… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …expires on March 7, 2030; U.S. Patent No. 8,354,430 expires on February 6, 2026. Thirty Month Stay Deadline…21 November 2023 1:23-cv-01340 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2023-11-21 | 4 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,486,947 B2; 8,207,197 B2; 8,354,430…21 November 2023 1:23-cv-01340 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
